- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
极度弱势行情中，投资者可暂时观望。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有49家主力机构披露2025-06-30报告期持股数据，持仓量总计2176.76万股，占流通A股12.09%
- 波段诊断：
-
技术面诊股
诊断结果：4.3技术面打败了21%的股票
技术面评分前10的股票
近期的平均成本为18.52元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为18.52元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"18.52","date":1774166684,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2026.03.23","stock":"-6.43","trade":null,"ind":"-3.76"},{"date":"2026.03.20","stock":"-2.97","trade":null,"ind":"-0.25"},{"date":"2026.03.19","stock":"-2.79","trade":null,"ind":"-2.02"},{"date":"2026.03.18","stock":"1.64","trade":null,"ind":"1.05"},{"date":"2026.03.17","stock":"-1.08","trade":null,"ind":"-1.87"},{"date":"2026.03.16","stock":"0.15","trade":null,"ind":"0.19"},{"date":"2026.03.13","stock":"1.45","trade":null,"ind":"-0.65"},{"date":"2026.03.12","stock":"-1.38","trade":null,"ind":"-0.63"},{"date":"2026.03.11","stock":"-1.02","trade":null,"ind":"0.78"},{"date":"2026.03.10","stock":"2.24","trade":null,"ind":"2.04"},{"date":"2026.03.09","stock":"-0.20","trade":null,"ind":"-0.74"},{"date":"2026.03.06","stock":"2.24","trade":null,"ind":"0.59"},{"date":"2026.03.05","stock":"0.25","trade":null,"ind":"1.23"},{"date":"2026.03.04","stock":"0.20","trade":null,"ind":"-0.75"},{"date":"2026.03.03","stock":"-2.69","trade":null,"ind":"-3.07"},{"date":"2026.03.02","stock":"-4.10","trade":null,"ind":"-0.20"},{"date":"2026.02.27","stock":"0.82","trade":null,"ind":"-0.06"},{"date":"2026.02.26","stock":"-0.67","trade":null,"ind":"0.19"},{"date":"2026.02.25","stock":"1.55","trade":null,"ind":"1.29"},{"date":"2026.02.24","stock":"0.68","trade":null,"ind":"1.36"},{"date":"2026.02.13","stock":"-0.24","trade":null,"ind":"-1.28"}]
正海生物,深证成指,医疗器械指数
压力支撑
该股压力位为18.38元，支撑位为17.82元。
[{"text":"\u538b\u529b\u4f4d","value":"18.38","date":1774195200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"17.82","date":1774195200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.7资金面打败了37%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：03月23日 16:31
| 机构今日流向(万元) | -914.36 | 机构5日流向(万元) | -3954.25 |
| 机构10日流向(万元) | -4878.32 | 机构20日流向(万元) | -10109.19 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加148.89万股，其中基金净减仓10家，主力净减仓10家，暂未发现中长期投资价值。
截止2025-06-30，共49家主力机构（基金47家，一般法人2家），持仓量总计2176.76万股，占流通A股12.09%
其中，基金持仓与2024-12-31相比：
增仓：5家 ，增持 4.84万股
减仓：15家 ，减持 85.23万股
新出现在主力名单中：23家 ，持有298.28万股
从主力名单中消失：33家 ，原持有69万股
其中，基金持仓与2024-12-31相比：
增仓：5家 ，增持 4.84万股
减仓：15家 ，减持 85.23万股
新出现在主力名单中：23家 ，持有298.28万股
从主力名单中消失：33家 ，原持有69万股
消息面诊股
诊断结果：5消息面打败了41%的股票
今日有利好新闻的公司
近期该股消息很少，消息面信号较弱。
更多>>个股资讯
- 正海生物：3月20日获融资买入458.05万元
2026-03-23 - 两大耗材联盟集采结果公布！
2026-03-20 - 正海生物：3月19日获融资买入798.12万元
2026-03-20 - 国家级荣誉再上榜！正海生物荣获“国家级绿色工厂”称
2026-03-19 - 正海生物：3月18日获融资买入543.27万元
2026-03-19 - 正海生物：3月17日获融资买入423.38万元
2026-03-18 - 正海生物：3月16日获融资买入406.51万元
2026-03-17 - 正海生物：3月13日获融资买入593.44万元
2026-03-16 - 京津冀“3+N”联盟公布两大耗材中选结果：留置针1
2026-03-13 - 正海生物：3月12日获融资买入482.41万元
2026-03-13
消息列表
| 一般消息 | 高管变动 | 因公司内部工作调整 | 2025-08-27 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-05 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-05 |
| 一般消息 | 高管变动 | 为进一步强化公司中长期发展战略制定... | 2025-08-04 |
| 利好 | 分红转增 | 10派4.6元(含税) | 2025-04-15 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了3%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.03.23","price":"-3.76","value":null},{"date":"2026.03.20","price":"-0.25","value":null},{"date":"2026.03.19","price":"-2.02","value":null},{"date":"2026.03.18","price":"1.05","value":null},{"date":"2026.03.17","price":"-1.87","value":null},{"date":"2026.03.16","price":"0.19","value":null},{"date":"2026.03.13","price":"-0.65","value":null},{"date":"2026.03.12","price":"-0.63","value":null},{"date":"2026.03.11","price":"0.78","value":null},{"date":"2026.03.10","price":"2.04","value":null},{"date":"2026.03.09","price":"-0.74","value":null},{"date":"2026.03.06","price":"0.59","value":null},{"date":"2026.03.05","price":"1.23","value":null},{"date":"2026.03.04","price":"-0.75","value":null},{"date":"2026.03.03","price":"-3.07","value":null},{"date":"2026.03.02","price":"-0.20","value":null},{"date":"2026.02.27","price":"-0.06","value":null},{"date":"2026.02.26","price":"0.19","value":null},{"date":"2026.02.25","price":"1.29","value":null},{"date":"2026.02.24","price":"1.36","value":null},{"date":"2026.02.13","price":"-1.28","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 九安医疗 | 46.79% | 11.33% | 5.3分 |
| 2 | 英科医疗 | 36.75% | -7.70% | 5.0分 |
| 3 | 蓝帆医疗 | 28.40% | -3.33% | 5.2分 |
| 4 | 中源协和 | 17.64% | -3.45% | 4.7分 |
| 5 | 康拓医疗 | 14.71% | 2.81% | 5.7分 |
| 6 | 亚辉龙 | 6.10% | -6.12% | 3.8分 |
| 8 | 心脉医疗 | 5.21% | -7.58% | 4.8分 |
| 10 | 中红医疗 | 3.98% | -12.14% | 4.9分 |
| 12 | 艾德生物 | 2.89% | -2.16% | 5.7分 |
| 14 | 基蛋生物 | 0.00% | 1.28% | 4.7分 |
| 16 | 万泰生物 | -1.74% | -2.81% | 4.0分 |
| 18 | 济民健康 | -2.17% | -4.04% | 4.3分 |
| 20 | 健信超导 | -3.61% | -10.40% | 5.4分 |
| 22 | 惠泰医疗 | -4.70% | -7.10% | 5.2分 |
| 24 | 可孚医疗 | -5.44% | -12.43% | 5.6分 |
| 26 | 圣湘生物 | -6.63% | -4.75% | 4.8分 |
| 28 | 安旭生物 | -7.05% | -7.59% | 3.7分 |
| 30 | 新产业 | -7.44% | -6.99% | 5.2分 |
| 32 | 佰仁医疗 | -7.99% | -7.06% | 3.8分 |
| 34 | 新华医疗 | -8.61% | -10.14% | 4.3分 |
| 36 | 东方海洋 | -8.89% | -18.00% | 4.5分 |
| 38 | ST凯利 | -9.06% | -9.35% | 4.8分 |
| 40 | 山东药玻 | -9.23% | -6.30% | 4.8分 |
| 42 | 东方生物 | -9.29% | -3.99% | 4.6分 |
| 44 | 安图生物 | -9.45% | -5.86% | 4.4分 |
| 46 | - | -9.88% | -8.23% | 分 |
| 48 | 理邦仪器 | -9.98% | -11.20% | 5.6分 |
| 50 | 迈克生物 | -10.44% | -9.27% | 3.7分 |
| 52 | 迈瑞医疗 | -10.85% | -6.57% | 5.0分 |
| 54 | 国发股份 | -11.26% | -0.50% | 4.7分 |
| 56 | 联影医疗 | -11.37% | -6.68% | 4.6分 |
| 58 | 海利生物 | -11.46% | -13.62% | 3.4分 |
| 60 | 科华生物 | -11.58% | -9.82% | 3.8分 |
| 62 | 天益医疗 | -11.80% | -20.62% | 3.9分 |
| 64 | 之江生物 | -11.85% | -7.43% | 3.7分 |
| 66 | 正海生物 | -11.87% | -11.26% | 3.9分 |
| 68 | 麦澜德 | -11.93% | -20.40% | 4.5分 |
| 70 | 凯普生物 | -12.06% | -10.34% | 3.8分 |
| 72 | 康德莱 | -12.39% | -12.30% | 4.6分 |
| 74 | 乐普医疗 | -12.71% | -15.70% | 5.1分 |
| 76 | 尚荣医疗 | -12.80% | -13.95% | 4.7分 |
| 78 | 爱威科技 | -13.03% | -14.00% | 4.8分 |
| 80 | 超研股份 | -13.18% | -9.08% | 5.4分 |
| 82 | 利德曼 | -13.37% | -11.35% | 4.6分 |
| 84 | 黄山胶囊 | -13.58% | -15.82% | 4.9分 |
| 86 | 三诺生物 | -13.89% | -7.99% | 5.0分 |
| 88 | 正川股份 | -13.99% | -12.76% | 4.0分 |
| 90 | 仁度生物 | -14.19% | -12.84% | 4.8分 |
| 92 | 大博医疗 | -14.51% | -9.82% | 5.0分 |
| 94 | 南微医学 | -14.85% | -8.64% | 4.8分 |
| 96 | 康泰医学 | -15.64% | -11.37% | 4.5分 |
| 98 | 奥精医疗 | -16.18% | -15.93% | 4.8分 |
| 100 | 迪瑞医疗 | -16.43% | -12.92% | 3.7分 |
| 102 | 瑞迈特 | -16.73% | -10.04% | 4.7分 |
| 104 | 麦克奥迪 | -17.24% | -13.20% | 4.5分 |
| 106 | 赛科希德 | -17.36% | -16.28% | 4.5分 |
| 108 | 乐心医疗 | -17.68% | -12.80% | 4.9分 |
| 110 | 昊海生科 | -17.97% | -10.35% | 4.9分 |
| 112 | 硕世生物 | -18.69% | -13.05% | 3.8分 |
| 114 | 天臣医疗 | -18.98% | -12.93% | 5.2分 |
| 116 | 楚天科技 | -19.15% | -12.73% | 4.3分 |
| 118 | 春立医疗 | -19.22% | -11.07% | 4.9分 |
| 120 | - | -19.81% | -11.93% | 分 |
| 122 | 港通医疗 | -20.08% | -12.73% | 4.3分 |
| 124 | 洁特生物 | -20.67% | -17.06% | 4.5分 |
| 126 | 三友医疗 | -20.94% | -14.98% | 4.3分 |
| 128 | 山外山 | -21.32% | -13.56% | 4.7分 |
| 130 | 安必平 | -21.43% | -14.88% | 3.9分 |
| 132 | 热景生物 | -21.84% | -14.58% | 3.4分 |
| 134 | 博拓生物 | -24.09% | -16.02% | 3.8分 |
| 136 | 华大智造 | -24.97% | -10.84% | 4.5分 |
| 138 | 美好医疗 | -30.76% | -14.48% | 4.9分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 27/243 ， 2/243。
[{"date":"2025-09-30","value":"7.65","vol":"2.98"},{"date":"2025-06-30","value":"5.34","vol":"2.34"},{"date":"2025-03-31","value":"2.95","vol":"1.16"},{"date":"2024-12-31","value":"14.66","vol":"0.56"},{"date":"2024-09-30","value":"13.57","vol":"4.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.65 | 5.34 | 2.95 | 14.66 | 13.57 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"85.03","vol":"51.74"},{"date":"2025-06-30","value":"83.92","vol":"52.05"},{"date":"2025-03-31","value":"80.96","vol":"51.42"},{"date":"2024-12-31","value":"87.64","vol":"52.52"},{"date":"2024-09-30","value":"87.61","vol":"53.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
85.03 | 83.92 | 80.96 | 87.64 | 87.61 |
| 行业(%) | 51.74 | 52.05 | 51.42 | 52.52 | 53.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 80/243 ， 92/243。
[{"date":"2025-09-30","value":"-5.36","vol":"0.26"},{"date":"2025-06-30","value":"-5.14","vol":"-1.09"},{"date":"2025-03-31","value":"8.68","vol":"-0.12"},{"date":"2024-12-31","value":"-12.19","vol":"1.15"},{"date":"2024-09-30","value":"-9.46","vol":"0.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-5.36 | -5.14 | 8.68 | -12.19 | -9.46 |
| 行业(%) | 0.26 | -1.09 | -0.12 | 1.15 | 0.77 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-46.10","vol":"-15.37"},{"date":"2025-06-30","value":"-45.97","vol":"-18.14"},{"date":"2025-03-31","value":"-34.06","vol":"-2.59"},{"date":"2024-12-31","value":"-29.49","vol":"-23.09"},{"date":"2024-09-30","value":"-15.69","vol":"-19.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-46.10 | -45.97 | -34.06 | -29.49 | -15.69 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -19.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 51/243 ， 74/243。
[{"date":"2025-09-30","value":"0.28","vol":"0.25"},{"date":"2025-06-30","value":"0.20","vol":"0.17"},{"date":"2025-03-31","value":"0.10","vol":"0.08"},{"date":"2024-12-31","value":"0.36","vol":"0.36"},{"date":"2024-09-30","value":"0.29","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.28 | 0.20 | 0.10 | 0.36 | 0.29 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.27","vol":"1.66"},{"date":"2025-06-30","value":"0.93","vol":"1.12"},{"date":"2025-03-31","value":"0.58","vol":"0.55"},{"date":"2024-12-31","value":"1.25","vol":"2.32"},{"date":"2024-09-30","value":"1.01","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.27 | 0.93 | 0.58 | 1.25 | 1.01 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"30.18","vol":"14.74"},{"date":"2025-06-30","value":"9.65","vol":"15.17"},{"date":"2025-03-31","value":"39.98","vol":"4.22"},{"date":"2024-12-31","value":"41.61","vol":"29.38"},{"date":"2024-09-30","value":"42.01","vol":"15.46"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 30.18 | 9.65 | 39.98 | 41.61 | 42.01 |
| 行业 | 14.74 | 15.17 | 4.22 | 29.38 | 15.46 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.41","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.68","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.41 | - | 0.68 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 107/243 ， 111/243。
[{"date":"2025-09-30","value":"8.89","vol":"5.66"},{"date":"2025-06-30","value":"8.92","vol":"5.47"},{"date":"2025-03-31","value":"8.70","vol":"5.84"},{"date":"2024-12-31","value":"8.82","vol":"5.30"},{"date":"2024-09-30","value":"9.93","vol":"5.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
8.89 | 8.92 | 8.70 | 8.82 | 9.93 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.83 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"8.40","vol":"4.51"},{"date":"2025-06-30","value":"8.43","vol":"4.35"},{"date":"2025-03-31","value":"8.32","vol":"4.73"},{"date":"2024-12-31","value":"8.34","vol":"4.27"},{"date":"2024-09-30","value":"9.36","vol":"4.70"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
8.40 | 8.43 | 8.32 | 8.34 | 9.36 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 107/243 ， 107/243。
[{"date":"2025-09-30","value":"9.37","vol":"22.07"},{"date":"2025-06-30","value":"9.26","vol":"22.01"},{"date":"2025-03-31","value":"9.52","vol":"21.19"},{"date":"2024-12-31","value":"9.32","vol":"21.94"},{"date":"2024-09-30","value":"8.45","vol":"20.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
9.37 | 9.26 | 9.52 | 9.32 | 8.45 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.60 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.10","vol":"0.71"},{"date":"2025-06-30","value":"0.10","vol":"0.58"},{"date":"2025-03-31","value":"0.11","vol":"0.56"},{"date":"2024-12-31","value":"0.10","vol":"0.55"},{"date":"2024-09-30","value":"0.09","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.10 | 0.10 | 0.11 | 0.10 | 0.09 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"1.69","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.85","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.91","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.35","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]